Eurofins Scientific SE (ESF0) - Cash Flow Conversion Efficiency

Latest as of December 2022: 0.069x

Based on the latest financial reports, Eurofins Scientific SE (ESF0) has a cash flow conversion efficiency ratio of 0.069x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€334.05 Million ≈ $390.54 Million USD) by net assets (€4.85 Billion ≈ $5.67 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Eurofins Scientific SE (ESF0) total market value for the company's overall valuation and market capitalisation.

Eurofins Scientific SE - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Eurofins Scientific SE's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Eurofins Scientific SE Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eurofins Scientific SE ranked by their cash flow conversion efficiency. Explore cash flow quality index of Eurofins Scientific SE to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Dayforce Inc.
NYSE:DAY
0.012x
Huaneng Power International Inc
SHG:600011
0.105x
Indian Railway Finance Corporation Limited
NSE:IRFC
-0.247x
Skanska AB (publ)
ST:SKA-B
0.121x
Hero MotoCorp Limited
NSE:HEROMOTOCO
0.164x
Pinterest Inc
NYSE:PINS
0.067x
JAMES HARDIE INDUST.ADR/1
F:JHA0
N/A
HDFC Asset Management Company Limited
NSE:HDFCAMC
0.130x

Annual Cash Flow Conversion Efficiency for Eurofins Scientific SE (2016–2025)

The table below shows the annual cash flow conversion efficiency of Eurofins Scientific SE from 2016 to 2025. View ESF0 stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €4.58 Billion
≈ $5.35 Billion
€1.40 Billion
≈ $1.64 Billion
0.306x +24.79%
2024-12-31 €5.38 Billion
≈ $6.30 Billion
€1.32 Billion
≈ $1.54 Billion
0.245x +23.62%
2023-12-31 €5.14 Billion
≈ $6.01 Billion
€1.02 Billion
≈ $1.19 Billion
0.198x -15.41%
2022-12-31 €4.85 Billion
≈ $5.67 Billion
€1.14 Billion
≈ $1.33 Billion
0.234x -27.51%
2021-12-31 €4.68 Billion
≈ $5.47 Billion
€1.51 Billion
≈ $1.77 Billion
0.323x -1.84%
2020-12-31 €3.72 Billion
≈ $4.34 Billion
€1.22 Billion
≈ $1.43 Billion
0.329x +40.74%
2019-12-31 €2.90 Billion
≈ $3.39 Billion
€677.90 Million
≈ $792.54 Million
0.234x +17.07%
2018-12-31 €2.72 Billion
≈ $3.18 Billion
€543.90 Million
≈ $635.88 Million
0.200x +22.41%
2017-12-31 €2.48 Billion
≈ $2.90 Billion
€405.12 Million
≈ $473.63 Million
0.163x -22.89%
2016-12-31 €1.76 Billion
≈ $2.05 Billion
€371.84 Million
≈ $434.72 Million
0.212x --

About Eurofins Scientific SE

F:ESF0 Germany Diagnostics & Research
Market Cap
$12.10 Billion
€10.35 Billion EUR
Market Cap Rank
#2051 Global
#428 in Germany
Share Price
€59.14
Change (1 day)
+0.03%
52-Week Range
€55.08 - €72.98
All Time High
€123.83
About

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection,… Read more